Satoshi Ikeda

Hirakata, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 159 publications

Five-Year Trends in Biomarker Testing and Targeted Therapy for NSCLC: A Patient-Initiated Nationwide Survey in Japan.

Five-Year Trends in Biomarker Testing and Targeted Therapy for NSCLC: A Patient-Initiated Nationwide Survey in Japan.

Journal: Cancer science

Published: May 29, 2026

Should supportive care be started before initiating cancer treatment?

Should supportive care be started before initiating cancer treatment?

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: May 21, 2026

Survival, toxicity, and sequencing: navigating the new first-line standard established by FLAURA2.

Survival, toxicity, and sequencing: navigating the new first-line standard established by FLAURA2.

Journal: Translational lung cancer research

Published: February 14, 2026

Nivolumab plus ipilimumab-based treatment in Japanese patients with metastatic non-small cell lung cancer and tumor PD-L1 < 1%: a pooled analysis.

Nivolumab plus ipilimumab-based treatment in Japanese patients with metastatic non-small cell lung cancer and tumor PD-L1 < 1%: a pooled analysis.

Journal: International journal of clinical oncology

Published: February 04, 2026

GW240925 and GW250207: Astrophysical Calibration of Gravitational Wave Detectors.

GW240925 and GW250207: Astrophysical Calibration of Gravitational Wave Detectors.

Journal: Physical review letters

Published: January 27, 2026

AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer.

AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer.

Journal: Molecular therapy. Oncology

Published: January 08, 2026

Targeting driver mutations in lung cancer with interstitial pneumonia: A nationwide study in Japan.

Targeting driver mutations in lung cancer with interstitial pneumonia: A nationwide study in Japan.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 18, 2025

Why Cemiplimab? Defining a Unique Therapeutic Niche in First-Line Non-Small-Cell Lung Cancer with Ultra-High PD-L1 Expression and Squamous Histology.

Why Cemiplimab? Defining a Unique Therapeutic Niche in First-Line Non-Small-Cell Lung Cancer with Ultra-High PD-L1 Expression and Squamous Histology.

Journal: Cancers

Published: December 10, 2025

Dysphagia after COVID-19 Vaccination: A Report of Two Cases.

Dysphagia after COVID-19 Vaccination: A Report of Two Cases.

Journal: Internal medicine (Tokyo, Japan)

Published: November 12, 2025

Rechallenge chemotherapy with carboplatin plus paclitaxel or nab-paclitaxel for patients with non-small cell lung cancer and interstitial lung disease: A multicenter retrospective study.

Rechallenge chemotherapy with carboplatin plus paclitaxel or nab-paclitaxel for patients with non-small cell lung cancer and interstitial lung disease: A multicenter retrospective study.

Journal: Cancer treatment and research communications

Published: November 12, 2025

Development of a clinical prediction model using digital device data for interstitial lung disease in patients with unresectable stage III non-small cell lung cancer treated with durvalumab.

Development of a clinical prediction model using digital device data for interstitial lung disease in patients with unresectable stage III non-small cell lung cancer treated with durvalumab.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: October 27, 2025

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Journal: Physical review letters

Published: September 12, 2025

Showing 1-12 of 159

Last Updated: 09/26/2026